BILL · 2019–20 SESSION
HB 1250: Marijuana product labeling
Regarding labeling of marijuana products.
Summary
- Allows statement on marijuana product labels describing the product's intended role in maintaining bodily structures or functions, provided claims are substantiated and not misleading.
- Prohibits marijuana product label information from containing claims that marijuana products diagnose, mitigate, treat, cure, or prevent any disease.
- Removes the express directive for the LCB to adopt certain labeling rules and adds the above bulleted requirements for product labels to statute.
From the House Bill Analysis 2019 (HB 1250), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 17, 2019
- Out of committeestopped here
- Passed House
- Passed Senate
- Governor
- Law
- Prime sponsor
- Sharon Wylie (D-49)
- Introduced
- January 17, 2019 in the House
- Last action
- January 13, 2020
- Companion bill
- SB 5298
- Budget
- Has a fiscal note
AN ACT Relating to labeling of marijuana products;
Sponsors
Prime sponsor: Sharon Wylie (D-49)
3 co-sponsors (2 Democrats, 1 Republican)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- First reading, referred to Commerce & Gaming.
HB 1250 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HB 1250 (2025–26) Law enf agency accreditation
- HB 1250 (2023–24) Low-income home rehab. prg.
- HB 1250 (2021–22) Purple heart state
- HB 1250 (2017–18) Marijuana/lockable drug box
- HB 1250 (2015–16) Notice and review processes
- HB 1250 (2013–14) Juveniles & runaway children
- HB 1250 (2011–12) Budget stabilization account
- HB 1250 (2009–10) Housing trust fund